United States
United States

Time filter

Source Type

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Orthopedic Bracing and Support Systems Market 2017-2021" report to their offering. The global orthopedic bracing and support systems market to grow at a CAGR of 4.35% during the period 2017-2021. The report, Global Thoracic Surgery Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. According to the report, one driver in market is cost-effective alternative in developing countries. Braces and supports are more economical than surgeries, and one does not need any special knowledge or skills to use them. For early osteoarthritis treatment in lower and upper extremities, orthopedic braces and support systems are used, which are cheaper compared with hip and knee replacement procedures. For instance, the estimated cost of a knee replacement surgery ranges between $70,000 and $90,000, which includes hospital stay, cost of implant, and other cost factors (medicines, nursing, and consultation fee). But if osteoarthritis is detected early, then braces and support systems can be used, which cost between $5,000 and $18,000 based on the type, thereby curbing the cost. These factors are driving the adoption of braces and support systems in developing countries. Additionally, medical treatments for certain musculoskeletal disorders, such as arthritis, are focused on maintaining joint movements and pain alleviation. Also, limited access to hospitals creates an opportunity for the adoption of braces and supports in rural areas. For more information about this report visit http://www.researchandmarkets.com/research/47gztz/global_orthopedic


The analysts forecast the global orthopedic bracing and support systems market to grow at a CAGR of 4.35% during the period 2017-2021. Orthopedic braces and support systems are used to restrict or assist physical movement, reduce weight-bearing forces, assist in recovery from fractures, and reduce pain. The proper selection and design of a suitable orthotic product help in the recovery of the affected joint and associated area of the limb. This, in turn, prevents further degenerative of the joints, muscles, and ligaments. The preference for non-invasive treatment is the major driving force in the market. Considering the operative trauma and the recovery time associated with invasive treatments, consumers tend to put off surgery in the case of injuries or other orthopedic conditions and rely on braces and supports for treatment. For more information or any query mail at sales@wiseguyreports.com The report covers the present scenario and the growth prospects of the global orthopedic bracing and support systems market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of various types of products, which are used for treatment purposes. The market is divided into the following segments based on geography: • Americas • APAC • EMEA The report, Global Thoracic Surgery Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. Other prominent vendors • Anatomical Concepts • Aspen Medical Products • Brace Orthopaedic • Breg • BSN medical • Cascade Dafo • FastForm Research • Green Sun Medical • Lethbridge Orthotic • Myomo • NIPPON SIGMAX • New Options Sports • Orthopaedic Appliances • PROTEOR • Promedionics • Redyns Medical • Rehband • Skeletal Support Systems • Spring Loaded Technology • Surgical Appliance Industries • TRULIFE • The Thuasne Group • United Ortho Market driver • Growing bone degeneration complications in elderly population. • For a full, detailed list, view our report Market challenge • High cost of orthopedic braces and increased pricing pressure. • For a full, detailed list, view our report Market trend • Growing popularity of minimally invasive procedures. • For a full, detailed list, view our report Key questions answered in this report • What will the market size be in 2021 and what will the growth rate be? • What are the key market trends? • What is driving this market? • What are the challenges to market growth? • Who are the key vendors in this market space? • What are the market opportunities and threats faced by the key vendors? • What are the strengths and weaknesses of the key vendors? PART 06: Market segmentation by product • Upper extremity bracing and support systems • Lower extremity bracing and support systems • Spinal bracing and support systems PART 07: Market segmentation by application • Joint replacement and fracture • Nerve diseases and soft tissue injuries PART 09: Geographical segmentation • Orthopedic bracing and support systems market in Americas • Orthopedic bracing and support systems market in EMEA • Orthopedic bracing and support systems market in APAC PART 11: Drivers and challenges • Market drivers • Impact of drivers on key customer segments • Market challenges • Impact of challenges on key customer segments For more information or any query mail at sales@wiseguyreports.com ABOUT US: Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of rmaket research reports under these categories and sub-categories. For more information, please visit https://www.wiseguyreports.com


"We are impressed by the immediate impact of the less-invasive Revivent TC system," said Dr. Kelle. "The patient achieved a 33% reduction in LVESVI and a 15% increase in the Ejection Fraction," continued Dr. Kelle. "The therapy provides a much-needed option for patients suffering from heart failure due to left ventricular anterior scar, particularly when medical therapy is no longer effective. We are impressed by the immediate improvements and are eager to learn about the long term results of this promising method," said Dr. Klein. "This patient's quality of life was severely impacted by his heart failure," said Dr. Hennig. "Especially for an older and more fragile population, the risks and recovery of surgery often preclude any meaningful intervention. The LIVE procedure eliminates the invasive elements associated with conventional surgical reconstruction. It expands the patient population that will be able to benefit from this procedure," continued Dr. Hennig. About BioVentrix and the Revivent TC System BioVentrix, a privately held medical technology company headquartered in San Ramon, Calif., is focused on developing and commercializing minimally invasive therapies for treating HF.  The company has received CE mark certification for its closed-chest Revivent TC TransCatheter Ventricular Enhancement System for plication of scar tissue in post-MI, ischemic cardiomyopathy patients. Placement of the Revivent TC System via the LIVE procedure obviates the need for more invasive surgery. Instead, small titanium anchors are placed along the outer surface of the heart and along one of the interior walls via a catheter-based approach. The anchors are then pulled towards one another, effectively excluding the scarred and non-functioning heart wall. Ventricular volume is immediately reduced as a result of the exclusion, by as much as 30-40 percent1. Click here for corporate video with animation Note: The Revivent TC System is approved for sale in Europe; it is not approved for sale in the United States. 1Wechsler, A. et al., Clinical benefits twelve months after less invasive ventricular restoration operations without ventriculotomy. Annual meeting of the European Society of Cardio-Thoracic Surgery, 07 Oct. 2013, Vienna, Austria. To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/bioventrix-announces-the-1st-revivent-tc-transcatheter-ventricular-enhancement-procedure-for-ischemic-cardiomyopathy-treatment-at-deutsches-herzzentrum-berlin-in-germany-300460446.html


"Creative Medical Technology Holdings will develop this patent through the same process that we are using for our clinical-stage Caverstem procedure for erectile dysfunction," stated Timothy  Warbington, President and Chief Executive Officer of the Company. "We plan to identify and engage key opinion leaders who will lead clinical trials, which will serve as the basis for accelerated commercialization." The Company is currently running a clinical trial using autologous non-manipulated bone marrow stem cells for patients suffering from erectile dysfunction that are non-responsive to standard approaches such as Viagra. Once the trial is completed, the results will serve as the basis for marketing of disposables utilized in administration of stem cells. "Although numerous companies are injecting stem cells directly into the disc, direct injection may only cause temporary benefit because the root cause of the pathology, in our opinion, is the reduced blood supply," stated Dr. Amit Patel, Director of Thoracic Surgery at University of Miami and co-founder of Creative Medical Technology Holdings. "By recreating in the microenvironment of the lower back the same thing that we do in atherosclerotic heart patients, we believe we have a novel way to treat this terrible condition that wreaks havoc on our health care system." Several studies have shown that administration of stem cells possesses a therapeutic effect in cardiac conditions associated with poor circulation by stimulation of new blood vessel production, a process termed "angiogenesis". The current patent covers stimulation of angiogenesis in the lower back using mesenchymal stem cells. These cells can be used from the same patient, which is considered an "autologous therapy" as well as using stem cells in a universal donor manner, which is termed "allogeneic". "The acquisition of this patent not only positions the company to expand into the disc degenerative space, but also provides a powerful platform for collaboration with other companies that are administering regenerative cells directly into the nucleus pulposus of the disc," commented Thomas Ichim, Ph.D., Chief Scientific Officer of the Company and inventor of the technology. "Stem cells are like seeds, they need to be planted into fertile soil.  We feel that in certain patients it is essential to treat the lumbar ischemia, which is present in some patients suffering from disc degenerative disease, which will then allow the stem cells administered directly in the disc to perform their regenerative effects." Creative Medical Technology Holdings, Inc. is a clinical-stage biotechnology company with two focus areas; 1) personalized stem cell procedures for sexual dysfunction and infertility, and 2) universal, off-the-shelf amniotic fluid-based stem cells that possess superior healing potential without negative medical or ethical issues. Through our own research and collaborations with leading academic institutions, we have developed proprietary protocols, built an extensive intellectual property portfolio, developed complete treatment offerings for erectile dysfunction and are performing ground-breaking research with our amniotic fluid-based stem cell. Forward-Looking Statements This release may contain "forward-looking statements." Forward-looking statements are identified by certain words or phrases such as "may", "aim", "will likely result", "believe", "expect", "anticipate", "estimate", "intend", "plan", "contemplate", "seek to", "future", "objective", "goal", "project", "should", "will pursue" and similar expressions or variations of such expressions. These forward-looking statements reflect the Company's current expectations about its future plans and performance. These forward-looking statements rely on a number of assumptions and estimates which could be inaccurate and which are subject to risks and uncertainties. Actual results could vary materially from those anticipated or expressed in any forward-looking statement made by the Company. Please refer to the Company's most recent Forms 10-Q and 10-K and subsequent filings with the SEC for a further discussion of these risks and uncertainties. The Company disclaims any obligation or intent to update the forward-looking statements in order to reflect events or circumstances after the date of this release. To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/creative-medical-technology-holdings-to-expand-into-10-billion-dollar-per-year-lower-back-pain-market-with-acquisition-of-issued-us-stem-cell-patent-300459902.html


The global orthopedic bracing and support systems market to grow at a CAGR of 4.35% during the period 2017-2021. The report, Global Thoracic Surgery Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. One trend in market is growing popularity of minimally invasive procedures. Traditional open surgeries can cause post-operative complications such as pain, partially collapsed lungs, blood clots, fatigue, muscle atrophy, and infections. The anesthesia administered before surgeries can cause nausea, sore throat, confusion, and sleepiness. To reduce such complications, medical facilities have started implementing minimally invasive techniques in their surgical procedures. According to the report, one driver in market is cost-effective alternative in developing countries. Braces and supports are more economical than surgeries, and one does not need any special knowledge or skills to use them. For early osteoarthritis treatment in lower and upper extremities, orthopedic braces and support systems are used, which are cheaper compared with hip and knee replacement procedures. For instance, the estimated cost of a knee replacement surgery ranges between $70,000 and $90,000, which includes hospital stay, cost of implant, and other cost factors (medicines, nursing, and consultation fee). But if osteoarthritis is detected early, then braces and support systems can be used, which cost between $5,000 and $18,000 based on the type, thereby curbing the cost. These factors are driving the adoption of braces and support systems in developing countries. Additionally, medical treatments for certain musculoskeletal disorders, such as arthritis, are focused on maintaining joint movements and pain alleviation. Also, limited access to hospitals creates an opportunity for the adoption of braces and supports in rural areas. Key Topics Covered: PART 01: Executive summary PART 02: Scope of the report PART 03: Research Methodology PART 04: Introduction PART 05: Market landscape PART 06: Market segmentation by product PART 07: Market segmentation by application PART 08: Market segmentation by end-user PART 09: Geographical segmentation PART 10: Decision framework PART 11: Drivers and challenges PART 12: Market trends PART 13: Vendor landscape PART 14: Key vendors PART 15: Appendix For more information about this report visit http://www.researchandmarkets.com/research/jzkksw/global_orthopedic Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/research-and-markets---global-orthopedic-bracing-and-support-systems-market-to-grow-at-a-cagr-of-435-by-2021---key-vendors-are-deroyal-industries-djo-global-ossur--zimmer-biomet-300458332.html


Leonard Octavius Barrett, MD, FACS, DDG, FABI, Thoracic Surgeon at Nassau University Medical Center, has been named a 2017 Top Doctor in East Meadow, New York. Top Doctor Awards is dedicated to selecting and honoring those healthcare practitioners who have demonstrated clinical excellence while delivering the highest standards of patient care. Dr. Leonard Octavius Barrett is a very experienced surgeon, having been in practice for over three decades. His career in medicine began in 1983, when he graduated from the State University of New York Downstate Medical College. After an internship and residency at Stony Brook University Hospital, Dr. Barrett completed a further residency at the Newark Beth Israel Medical Center, before undertaking a fellowship at Winthrop-University Hospital in Mineola, New York. Dr. Barrett is board certified in Surgery, Surgical Critical Care, and Thoracic and Cardiac Surgery, and he has become known as one of New York’s leading thoracic surgeons. He treats a wide range of conditions for patients across the age spectrum, including heart murmurs and arrhythmias, carotid artery disease, vascular disease, and lung cancer. He currently serves as Chief of Thoracic Surgery and Director of Surgical Critical Care at the Nassau University Medical Center. Dr. Barrett is committed to keeping up to date with the latest advances in the field of thoracic surgery, and he does through his membership of professional organizations including the Society of Critical Medicine and the American Society of Thoracic Surgery. He has earned the coveted title of Fellow of the American College of Surgeons, and his dedication and commitment makes Dr. Leonard Octavius Barrett a very deserving winner of a 2017 Top Doctor Award. Top Doctor Awards specializes in recognizing and commemorating the achievements of today’s most influential and respected doctors in medicine. Our selection process considers education, research contributions, patient reviews, and other quality measures to identify top doctors.


News Article | May 1, 2017
Site: www.prweb.com

A new study out of Hyogo, Japan suggests that mesothelioma patients who relapse after extrapleural pneumonectomy (EPP) surgery may extend their survival with additional rounds of chemotherapy. Surviving Mesothelioma has just posted news of the report on its website. Click here to read the details. The Hyogo College of Medicine study focused on 39 patients with malignant mesothelioma whose cancer started growing again in the months after they had lung-removing EPP surgery. The median time to relapse was just under a year. According to the study in the International Journal of Clinical Oncology, mesothelioma patients who underwent additional chemotherapy after relapse experienced better outcomes. “The median survival time after EPP was significantly longer in 21 patients who received additional chemotherapy than in 18 patients who did not,” says Dr. Teruhisa Takuwa with Department of Thoracic Surgery at Hyogo College of Medicine. “The treatment path is not always clear for mesothelioma patients after first-line therapy fails, since there is no universally-accepted second-line treatment” says Alex Strauss, Managing Editor for Surviving Mesothelioma. “With median mesothelioma survival times more than three years after surgery, this study suggests that there is reason to hope, even after relapse.” To read the details of the new study including a comparison of survival times between patients who did and did not have additional chemotherapy, see Additional Chemotherapy Extends Survival in Relapsed Mesothelioma Patients, now available on the Surviving Mesothelioma website. Takuwa, T, et al, Post-recurrence chemotherapy for mesothelioma patients undergoing extrapleural pneumonectomy”, April 24, 2017, International Journal of Clinical Oncology, Epub ahead of print, https://link.springer.com/article/10.1007/s10147-017-1126-x For more than a decade, Surviving Mesothelioma has brought readers the most important and ground-breaking news on the causes, diagnosis and treatment of mesothelioma. All Surviving Mesothelioma news is gathered and reported directly from the peer-reviewed medical literature. Written for patients and their loved ones, Surviving Mesothelioma news helps families make more informed decisions.


DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Online Electronics Retailing Market 2017-2021" report to their offering. The global online electronics retailing market to grow at a CAGR of 14.31% during the period 2017-2021. The report, Global Thoracic Surgery Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. One trend in market is cross-border e-commerce. As the global economic growth is transforming the world into a global marketplace, online merchants, card processors, and payment solution providers are learning how to collaborate with each other and overcome technical and business hurdles. Canada accounts for the highest share of online cross-border shoppers across the globe. Also, French cross-border shoppers purchase products from online retailers in Canada. Over three-fourths of the overall German online retailers in German-speaking countries such as Austria and Switzerland engage in cross-border e-commerce. France also accounts for the same percentage where shoppers and merchants engage in cross-border e-commerce with economies such as Belgium and Switzerland. For more information about this report visit http://www.researchandmarkets.com/research/fnd9jj/global_online


— The global market for radiation detection and monitoring is expected to be driven by the increasing demand from key end-users such as nuclear power plants and defense and military. The increasing construction of nuclear power plants in developing countries in APAC is expected to drive the market during the forecast period. Publisher's analysts forecast the global radiation detection and monitoring market to grow at a CAGR of 5.36% during the period 2017-2021. Covered in this report The report covers the present scenario and the growth prospects of the global radiation detection and monitoring market for 2017-2021. To calculate the market size, the report considers the revenue generated from radiation detection and monitoring. The market is divided into the following segments based on geography: - Americas - APAC - EMEA Publisher's report, Global Thoracic Surgery Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. Get Sample of the Report at: http://www.reportsweb.com/inquiry&RW0001608771/sample . Market driver - Rising use of radiation in manufacturing industries - For a full, detailed list, view our report Market challenge - Difficulties in large area monitoring - For a full, detailed list, view our report Market trend - Growing nuclear power plants in APAC - For a full, detailed list, view our report PART 01: Executive summary PART 02: Scope of the report PART 03: Market research methodology PART 04: Introduction PART 05: Global radiation detection and monitoring market PART 06: Market segmentation by end-user PART 07: Market segmentation by product type PART 08: Geographical segmentation PART 09: Market drivers PART 10: Impact of drivers PART 11: Market challenges PART 12: Impact of drivers and challenges PART 13: Market trends PART 14: Vendor landscape PART 15: Key vendor analysis PART 16: Appendix For more information, please visit http://www.reportsweb.com/global-radiation-detection-and-monitoring-market-2017-2021


New Market Research Reports Title "Global Hybrid Operating Room Market To Reach Worth USD 9.7 Bn By 2022: Credence Research" Has Been Added to Credenceresearch.com Report Database. San Jose, CA, April 20, 2017 --( Browse the full report Hybrid Operating Room Market: Growth, Future Prospects and Competitive Analysis, 2016-2022 report at http://www.credenceresearch.com/report/hybrid-operating-room-market Market Insights Hybrid operating rooms are extremely complex working environments where a large team of surgeons, interventionalists, nurses, anesthesiologists, and technicians need to work seamlessly together. A hybrid OR (Operating Room) is an alternative to conventional OR equipped with advanced medical imaging systems and devices supporting high quality interventional imaging and minimally invasive surgeries. North America held the largest regional market, accounting for the market share of over 37.3% in 2015, and is anticipated to dominate the global hybrid operating room market during the forecast period of 2016 to 2022. Rising number of hybrid operating room facilities and higher acceptance of technology are the key factors driving the North America hybrid operating room market. Asia Pacific is expected to grow at a highest growth rate during the focus period, due to rising medical tourism in the region, growing medical investments and healthcare infrastructure in Asia Pacific. Browse All Reports of This Category @ http://www.credenceresearch.com/industry/medical-devices-market Among the devices types, intraoperative diagnostic devices held the largest share in the global hybrid operating room market due to its wider application in the cardiovascular and neurosurgery. Moreover, rising minimally invasive surgeries would further enhance the application of intraoperative diagnostic devices driving the market further. The therapeutic application held the largest share in the global hybrid operating room market. The cardiovascular surgeries dominated the therapeutic application segment owing to the rise in the prevalence of cardiovascular diseases worldwide. The diagnostic imaging is anticipated to exhibit fastest growth rate in the hybrid operating room market. Rising number of minimally invasive surgery and robotic surgery to drive the diagnostic imaging market. Hospitals held the largest share in the end user segment of the global hybrid operating room market. Rising number of hospitals coming up with hybrid operating room is the major factor driving the hybrid operating room market. Clinics are expected to be the fastest growing end user segment in the global hybrid operating room market. Blog URL - http://www.mobilecomputingtoday.co.uk/4193/global-hybrid-operating-room-market-reach-worth-usd-9-7-2022-rising-demand-minimally-invasive-surgery-drive-market-credence-research/ About Credence Research: Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task. For More Information, Visit: Credence Research Media Contact Company Name: Credence Research Contact Person: Chris Smith, Designation: Global Sales Manager Phone: 1-800-361-8290 Address: 105 N 1st ST #429, San Jose, CA 95103 E-mail: sales@credenceresearch.com San Jose, CA, April 20, 2017 --( PR.com )-- According to the latest report published by Credence Research, Inc. “Hybrid Operating Room Market – (Device Type - Operating Tables, Lighting Systems, Surgical Beams, Surgical Imaging Displays, Intraoperative Diagnostic Devices and Operating Room Communication Systems; Application Type - Therapeutic: Cardiovascular Surgeries, Neurosurgery, Thoracic Surgery, Biopsy, Orthopedic Surgeries, Laparoscopic Surgeries, Emergency Care And Other Surgeries, Diagnostics: Fluoroscopy, Digital Subtraction Angiography, And 3D C-Arm Computer Tomography; End User – Hospitals, Clinics, Medical Research Institute And Ambulatory Surgical Centers) :Market Growth, Future Prospects and Competitive Analysis, 2016-2022,” the market was valued at USD 3.4 Bn in 2015, and is expected to reach USD 9.7 Bn by 2022, expanding at a CAGR of 16.1% from 2016 to 2022.Browse the full report Hybrid Operating Room Market: Growth, Future Prospects and Competitive Analysis, 2016-2022 report at http://www.credenceresearch.com/report/hybrid-operating-room-marketMarket InsightsHybrid operating rooms are extremely complex working environments where a large team of surgeons, interventionalists, nurses, anesthesiologists, and technicians need to work seamlessly together. A hybrid OR (Operating Room) is an alternative to conventional OR equipped with advanced medical imaging systems and devices supporting high quality interventional imaging and minimally invasive surgeries. North America held the largest regional market, accounting for the market share of over 37.3% in 2015, and is anticipated to dominate the global hybrid operating room market during the forecast period of 2016 to 2022. Rising number of hybrid operating room facilities and higher acceptance of technology are the key factors driving the North America hybrid operating room market. Asia Pacific is expected to grow at a highest growth rate during the focus period, due to rising medical tourism in the region, growing medical investments and healthcare infrastructure in Asia Pacific.Browse All Reports of This Category @ http://www.credenceresearch.com/industry/medical-devices-marketAmong the devices types, intraoperative diagnostic devices held the largest share in the global hybrid operating room market due to its wider application in the cardiovascular and neurosurgery. Moreover, rising minimally invasive surgeries would further enhance the application of intraoperative diagnostic devices driving the market further.The therapeutic application held the largest share in the global hybrid operating room market. The cardiovascular surgeries dominated the therapeutic application segment owing to the rise in the prevalence of cardiovascular diseases worldwide. The diagnostic imaging is anticipated to exhibit fastest growth rate in the hybrid operating room market. Rising number of minimally invasive surgery and robotic surgery to drive the diagnostic imaging market.Hospitals held the largest share in the end user segment of the global hybrid operating room market. Rising number of hospitals coming up with hybrid operating room is the major factor driving the hybrid operating room market. Clinics are expected to be the fastest growing end user segment in the global hybrid operating room market.Blog URL - http://www.mobilecomputingtoday.co.uk/4193/global-hybrid-operating-room-market-reach-worth-usd-9-7-2022-rising-demand-minimally-invasive-surgery-drive-market-credence-research/About Credence Research:Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.For More Information, Visit: Credence ResearchMedia ContactCompany Name: Credence ResearchContact Person: Chris Smith,Designation: Global Sales ManagerPhone: 1-800-361-8290Address: 105 N 1st ST #429, San Jose,CA 95103E-mail: sales@credenceresearch.com Click here to view the list of recent Press Releases from Credence Research

Loading Thoracic Surgery collaborators
Loading Thoracic Surgery collaborators